Acucela Inc - Company & Market Research Reports

Acucela Inc., a Kubota Pharmaceutical Group company, is committed to translating innovation into a diverse portfolio of drugs and devices to treat blinding eye diseases that affect tens of millions of people worldwide. The company's orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acuity, have the potential to be used to treat several devastating eye diseases, including dry age-related macular degeneration (AMD). Acucela was founded by Dr. Ryo Kubota in 2002.

From
From
From
From
From
From
From
From
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • 106 Pages
From
Retinal Degeneration - Pipeline Insight, 2018 - Product Thumbnail Image

Retinal Degeneration - Pipeline Insight, 2018

  • Drug Pipelines
  • 217 Pages
From
From
Cataract - Pipeline Review, H2 2018 - Product Thumbnail Image

Cataract - Pipeline Review, H2 2018

  • Drug Pipelines
  • 45 Pages
From
From
Geographic Atrophy - Pipeline Review, H2 2018 - Product Thumbnail Image

Geographic Atrophy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 79 Pages
From
Loading Indicator
adroll